| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00007890-200209150-00017 |
| P698 | PubMed publication ID | 12352887 |
| P50 | author | Ronald W Busuttil | Q87949429 |
| P2093 | author name string | Drew J Winston | |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluconazole | Q411478 |
| randomized controlled trial | Q1436668 | ||
| P304 | page(s) | 688-695 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients | |
| P478 | volume | 74 |
| Q33385491 | A risk profile for invasive aspergillosis in liver transplant recipients |
| Q24242984 | Antacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patients |
| Q24246678 | Antifungal agents for preventing fungal infections in solid organ transplant recipients |
| Q38268056 | Antifungal prophylaxis in liver transplantation: a systematic review and network meta-analysis. |
| Q37879201 | Antifungal prophylaxis in solid organ transplant recipients |
| Q35558478 | Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patients |
| Q33719294 | Aspergillus infections in transplant recipients |
| Q44703532 | Clinical evaluation of ERCP and naobiliary drainage for biliary fungal infection--a report of five cases of severe combined bacterial and fungal infection of biliary tract |
| Q35622740 | Current status of liver transplantation in children |
| Q44346631 | Cytochrome P450 epoxygenase dependence of opioid analgesia: fluconazole does not interfere with remifentanil-mediated analgesia in human subjects |
| Q40377329 | Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients |
| Q44595697 | Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study |
| Q34490092 | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? |
| Q62618463 | Influence of Infection by Aspergillus in Arterial Complications After Liver Transplantation: Evolution and Results in 670 Transplants |
| Q37854721 | Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation |
| Q46903637 | Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. |
| Q46434488 | Invasive fungal infections in patients after liver transplantation |
| Q35917270 | Itraconazole (Sporanox) in superficial and systemic fungal infections |
| Q37098160 | Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts? |
| Q35790799 | Novel approaches to antifungal prophylaxis |
| Q42025881 | Prophylaxis of fungal infections in transplant patients |
| Q84784151 | Prophylaxis of invasive mycoses in solid organ transplantation |
| Q37327097 | Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients? |
| Q40140249 | Single-center experience of antifungal prophylaxis for coccidioidomycosis in heart transplant recipients within an endemic area |
| Q36670902 | Strategies for the prevention of infection after solid organ transplantation |
| Q33254158 | Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients |
| Q44606392 | Systemic antifungal agents |
| Q35194743 | Targeted versus universal antifungal prophylaxis among liver transplant recipients |
| Q38174023 | Tolerance--is it worth it? |
| Q58719932 | Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis |
| Q44506237 | Use of antifungal agents in pediatric and adult high-risk areas |
| Q80510457 | [Infections in liver transplant recipients] |
Search more.